Siyi Wu

Development and validation of a nomogram for predicting the status of estrogen receptor-low-positive breast cancer

Yueping Liu, Meng Han, S. Niu, 2021, Translational Breast Cancer Research.

MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer

Xin Hu, Xiao-En Xu, Z. Shao, 2021, Journal for ImmunoTherapy of Cancer.

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Hong-wei Zhang, L. Fan, Keda Yu, 2019, Cancer.

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer

Xin Hu, Xiao-En Xu, Z. Shao, 2021, Journal for ImmunoTherapy of Cancer.

Development and Validation of a Novel Model for Predicting Prognosis of Non-PCR Patients After Neoadjuvant Therapy for Breast Cancer

Yueping Liu, Meng Han, Jinze Li, 2021, Frontiers in Oncology.

Adjuvant radiotherapy may have significant survival benefits for gastric cancer patients with 1-29 lymph nodes retrieved

Q. Song, Q. Hu, Y. Chu, 2020, Translational cancer research.